太原肛门口长了个包山西便血挂什么科室,山西长痔疮动手术多少钱,结肠炎怎么治山西,太原肛肠专科门诊,太原屁眼周围特别痒,太原痔疮息肉,太原做肠镜需要多长时间

WASHINGTON, May 4 (Xinhua) -- The U.S. National Aeronautics and Space Administration (NASA) announced Wednesday that its Gravity Probe B (GP-B) mission has confirmed two key predictions derived from Albert Einstein's general theory of relativity, which the spacecraft was designed to test.The experiment, launched in 2004, used four ultra-precise gyroscopes to measure the hypothesized geodetic effect, the warping of space and time around a gravitational body, and frame- dragging, the amount a spinning object pulls space and time with it as it rotates.GP-B determined both effects with unprecedented precision by pointing at a single star, IM Pegasi, while in a polar orbit around Earth. If gravity did not affect space and time, GP-B's gyroscopes would point in the same direction forever while in orbit. But in confirmation of Einstein's theories, the gyroscopes experienced measurable, minute changes in the direction of their spin, while Earth's gravity pulled at them.The findings are available online in the journal Physical Review Letters."Imagine the Earth as if it were immersed in honey. As the planet rotates, the honey around it would swirl, and it's the same with space and time," said Francis Everitt, GP-B principal investigator at Stanford University. "GP-B confirmed two of the most profound predictions of Einstein's universe, having far- reaching implications across astrophysics research."GP-B is one of the longest running projects in NASA history, with agency involvement starting in the fall of 1963 with initial funding to develop a relativity gyroscope experiment. Subsequent decades of development led to groundbreaking technologies to control environmental disturbances on spacecraft, such as aerodynamic drag, magnetic fields and thermal variations. The mission's star tracker and gyroscopes were the most precise ever designed and produced.GP-B completed its data collection operations and was decommissioned in December 2010."The mission results will have a long-term impact on the work of theoretical physicists," said Bill Danchi, senior astrophysicist and program scientist at NASA Headquarters in Washington. "Every future challenge to Einstein's theories of general relativity will have to seek more precise measurements than the remarkable work GP-B accomplished."

KIGALI, Feb. 8 (Xinhua) -- Li Zhaozhuo, vice chairman of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), will head a high-level delegation to Rwanda this month to boost friendly and cooperative ties between the two countries.According to a statement released by Rwanda's Senate on Tuesday, the three-day visit will begin on Feb. 18 and is to strengthen regular contacts between Rwandan and Chinese parliamentary chambers on a number of issues and review bilateral projects.Chinese Ambassador to Rwanda Shu Zhan has confirmed that the official delegation from China is "planning an outreach visit" to Rwanda.After a meeting with the Chinese envoy to Rwanda on Tuesday, the president of Rwanda's Senate, Vincent Biruta, said his country's legislative chambers would continue to promote friendly ties with the CPPCC and play a "constructive role" in promoting bilateral cooperation.Rwanda have received training assistance from China in the applications of information communication technology (ICT) in parliaments.The Central African nation has a long-standing bilateral relationship with China in a number of socio-economic areas such as infrastructure, energy, education, health, agriculture and communications.

WASHINGTON, April 25 (Xinhua) -- A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.Working in cell lines from colorectal cancer patients, researchers found that the class of drugs called PARP inhibitors worked against tumors with mutations in the MRE11 gene.About 15 percent of all colorectal cancers have what's called microsatellite instability, a type of error in the DNA. About 82 percent of those tumors have the MRE11 gene mutation."This is a potential broader application for PARP inhibitors, beyond breast and ovarian cancer. This is a class of drug that's already shown safety in early clinical trials and now might benefit some colorectal cancer patients as well," says lead study author Eduardo Vilar-Sanchez, a hematology/oncology fellow at the university, in a statement.The study, which was published Monday in Cancer Research, also found that PARP inhibitors are even more effective when both copies of MRE11 were mutated. Each person carries two copies of each gene, which means mutations can occur in either one or both copies. The researchers suggest that PARP inhibitors could be targeted specifically to colorectal cancer patients who have two copies of the mutated gene.Researchers are planning a phase I clinical trial to look at using PARP inhibitors in colorectal cancer patients with two mutated copies of MRE11. Future trials are being considered using PARP inhibitors to prevent colorectal cancer and other cancers in people with Lynch syndrome whose tumors have this mutation.Microsatellite instability is also seen in prostate cancer and endometrial cancer, suggesting potential for PARP inhibitors to play a role in additional types of cancer as well, Vilar-Sanchez says, adding that more research is needed in these areas.

NEW DELHI, March 5 (Xinhua) -- Doctors in India have claimed to have successfully performed a rare robotic heart surgery on a 23- year-old person at a hospital in the southern Indian city of Chennai, local media reported Saturday.Dr. R. Ravi Kumar, the Director of the Institute of Cardiovascular Disease at the Chettinad Health City, said the robotically assisted procedure involved replacing both the mitral and the aortal valve simultaneously.The surgery carried out on D. Vijayakanth, an auto driver from Vellore, was done by a three armed robot, took four hours and cost 225,000 rupees (4,500 U.S. dollars)."The best part about using a robot in cardiac surgery is that the patient's heart need not be opened and the surgery can be done using a small 4cm incision. This is not possible with normal surgeries without a robot," Dr Ravi Kumar was quoted by local daily The Times of India as saying.Robotic surgery, which is fairly new in the country, can be used for a gamut of medical procedures, said Dr Ravi Kumar."It requires a lot of precision and intense training because though the robotic hands do the surgery, it has to be controlled by a trained surgeon. One of the biggest disadvantages is the lack of sensory perception which is there when the surgeon actually does the surgery himself," he said.

BEIJING, Feb. 12 (Xinhua) -- A delegation of the Chinese People's Political Consultative Conference (CPPCC) left Beijing Saturday evening to visit Ghana, Rwanda and Mozambique.The delegation, led by Vice Chairman Li Zhaozhuo of the CPPCC National Committee, was invited by the Parliament of Ghana, the Rwandan Chamber of Deputies and the Parliament of Mozambique.